Literature DB >> 12485945

Expression and cyclic variability of CYP3A4 and CYP3A7 isoforms in human endometrium and cervix during the menstrual cycle.

Mohamadi A Sarkar1, Vijay Vadlamuri, Shobha Ghosh, Douglas D Glover.   

Abstract

CYP3A4, a cytochrome p450 (p450) isoform metabolizes estrogens, whereas CYP3A7, a fetal liver p450 isoform, is involved in estriol biosynthesis. The goal of this study was to evaluate expression of these enzymes in human uterine tissue during the proliferative and secretory phases of the menstrual cycle. Endometrium and cervix specimens were collected from women undergoing hysterectomy (n = 36). Total mRNA was extracted, quantified, and reverse-transcription polymerase chain reaction (RT-PCR) was carried out using consensus primers for CYP3A. The 453 base pairs PCR product was hybridized with specific internal oligonucleotide probes for CYP3A4 or CYP3A7 end labeled with (32)P gamma-ATP. The relative intensity of hybridization was determined by autoradiography. Expression of CYP3A7 in endometrium was significantly greater (approximately 10-fold) in the proliferative phase compared with the secretory phase (p < 0.05). CYP3A4 expression was comparable between the two phases. Expression of both enzymes was minimal in the cervix. Fluorescence in situ hybridization of paraffinized sections indicated localized expression of CYP3A enzymes in the glandular epithelium as well as the stroma. Comparison of relative fluorescence intensity indicated differential expression of CYP3A7 in various phases of the menstrual cycle. These results suggest that CYP3A expression in the endometrium of premenopausal women may vary depending on the menstrual cycle phase.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12485945     DOI: 10.1124/dmd.31.1.1

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  13 in total

Review 1.  Cytochrome P450 3A and their regulation.

Authors:  Oliver Burk; Leszek Wojnowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-21       Impact factor: 3.000

Review 2.  Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds.

Authors:  E J Reschly; Matthew D Krasowski
Journal:  Curr Drug Metab       Date:  2006-05       Impact factor: 3.731

Review 3.  Significance of the minor cytochrome P450 3A isoforms.

Authors:  Ann K Daly
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  Marijuana-derived cannabinoids inhibit uterine endometrial stromal cell decidualization and compromise trophoblast-endometrium cross-talk.

Authors:  Naveen K Neradugomma; Kaitlyn Drafton; Gil G Mor; Qingcheng Mao
Journal:  Reprod Toxicol       Date:  2019-05-30       Impact factor: 3.143

Review 5.  Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism.

Authors:  Haixing Li; Jed N Lampe
Journal:  Arch Biochem Biophys       Date:  2019-08-22       Impact factor: 4.013

6.  Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV.

Authors:  Jeremiah D Momper; Brookie M Best; Jiajia Wang; Edmund V Capparelli; Alice Stek; Emily Barr; Martina L Badell; Edward P Acosta; Murli Purswani; Elizabeth Smith; Nahida Chakhtoura; Kyunghun Park; Sandra Burchett; David E Shapiro; Mark Mirochnick
Journal:  AIDS       Date:  2018-11-13       Impact factor: 4.177

7.  Is cytochrome P450 3A4 regulated by menstrual cycle hormones in control endometrium and endometriosis?

Authors:  Carla A Piccinato; Rosa M Neme; Natália Torres; Renata Silvério; Vanessa Bitencourt Pazzini; Júlio C Rosa E Silva; Rui A Ferriani
Journal:  Mol Cell Biochem       Date:  2016-12-19       Impact factor: 3.396

8.  Changes to methadone clearance during pregnancy.

Authors:  Kim Wolff; Annabel Boys; Amin Rostami-Hodjegan; Alastair Hay; Duncan Raistrick
Journal:  Eur J Clin Pharmacol       Date:  2005-10-29       Impact factor: 2.953

9.  Identification of Selective CYP3A7 and CYP3A4 Substrates and Inhibitors Using a High-Throughput Screening Platform.

Authors:  Md Kabir; Elias C Padilha; Pranav Shah; Ruili Huang; Srilatha Sakamuru; Eric Gonzalez; Lin Ye; Xin Hu; Mark J Henderson; Menghang Xia; Xin Xu
Journal:  Front Pharmacol       Date:  2022-07-01       Impact factor: 5.988

10.  Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV.

Authors:  Jeremiah D Momper; Jiajia Wang; Alice Stek; David E Shapiro; Gwendolyn B Scott; Mary E Paul; Irma L Febo; Sandra Burchett; Elizabeth Smith; Nahida Chakhtoura; Kayla Denson; Kittipong Rungruengthanakit; Kathleen George; Derek Z Yang; Edmund V Capparelli; Mark Mirochnick; Brookie M Best
Journal:  AIDS       Date:  2021-07-01       Impact factor: 4.632

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.